miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer

miRNAs are 20-22 long nucleotide non-coding ribonucleic acid molecules critical to the modulation of molecular pathways. Immune evasion and the establishment of a suitable tumor microenvironment are two major contributors that support tumor invasion and metastasis. Tumorigenic miRNAs support these t...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2022-11, Vol.23 (22), p.13822
Main Authors: Kousar, Kousain, Ahmad, Tahir, Abduh, Maisa S, Kanwal, Balquees, Shah, Syeda Saba, Naseer, Faiza, Anjum, Sadia
Format: Article
Language:English
Subjects:
Angiogenesis
Antigens
Biosynthesis
Breast cancer
Cell proliferation
Cell therapy
Chemoresistance
Chemotherapy
Cytoplasm
Cytotoxicity
Dendritic cells
Desensitization
Enzymes
Epigenetics
Genomes
Helper cells
Humans
Immune checkpoint
Immune system
Immunologic Factors
Immunological tolerance
Immunology
Immunoregulation
Immunotherapy
Ligands
Lymphocytes
Lymphocytes T
Macrophages
Metabolism
Metastases
Metastasis
MicroRNAs
MicroRNAs - metabolism
miRNA
Neoplasms - genetics
Neoplasms - therapy
Nucleotides
Oncolysis
Proteins
Review
RNA polymerase
Self
Tumor microenvironment
Tumor Microenvironment - genetics
Tumor suppressor genes
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c415t-dfd56de0d4ff9f081012dc773426f75c4ee76be37da7540d317f8fe2a6d3a7933
cites cdi_FETCH-LOGICAL-c415t-dfd56de0d4ff9f081012dc773426f75c4ee76be37da7540d317f8fe2a6d3a7933
container_end_page
container_issue 22
container_start_page 13822
container_title International journal of molecular sciences
container_volume 23
creator Kousar, Kousain
Ahmad, Tahir
Abduh, Maisa S
Kanwal, Balquees
Shah, Syeda Saba
Naseer, Faiza
Anjum, Sadia
description miRNAs are 20-22 long nucleotide non-coding ribonucleic acid molecules critical to the modulation of molecular pathways. Immune evasion and the establishment of a suitable tumor microenvironment are two major contributors that support tumor invasion and metastasis. Tumorigenic miRNAs support these two hallmarks by desensitizing important tumor-sensitive regulatory cells such as dendritic cells, M1 macrophages, and T helper cells towards tumors while supporting infiltration and proliferation of immune cells like Treg cells, tumor-associated M2 macrophages that promote self-tolerance and chronic inflammation. miRNAs have a significant role in enhancing the efficacies of immunotherapy treatments like checkpoint blockade therapy, adoptive T cell therapy, and oncolytic virotherapy in cancer. A clear understanding of the role of miRNA can help scientists to formulate better-targeted treatment modalities. miRNA therapeutics have emerged as diverse class of nucleic acid-based molecules that can suppress oncogenic miRNAs and promote the expression of tumor suppressor miRNAs.
doi_str_mv 10.3390/ijms232213822
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9699074</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2739442867</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-dfd56de0d4ff9f081012dc773426f75c4ee76be37da7540d317f8fe2a6d3a7933</originalsourceid><addsrcrecordid>eNpdkUtLJDEUhcOgjI66dCsBNy6smbyqUrURpJmHoCNIuw6xcmOnqSRtUiW4nV8-sdVGXSVwvntuTg5Ch5R857wjP9zSZ8YZo7xl7AvapYKxipBGbr2776BvOS8JKWDdfUU7vBGccFLvon_e3fw9z9gFfAP306BHFwOOFs8nHxO-cn2KEB5disFDGE_xbAE-jgtIevVURrLLow49nOIL76ewUa6ieTPTweD1FjxfizCNrl9vnD1Ppn20bfWQ4eD13EO3v37OZ3-qy-vfF7Pzy6oXtB4rY03dGCBGWNtZ0lJCmeml5II1Vta9AJDNHXBptKwFMZxK21pgujFcy47zPXT24rua7jyYvsRJelCr5LxOTypqpz4qwS3UfXxUXdN1RIpicPJqkOLDBHlU3uUehkEHiFNWTApSk1ZIWtDjT-gyTimUeIXinRCsbWShqheqfHLOCezmMZSo53bVh3YLf_Q-wYZ-q5P_BypNo1k</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2739442867</pqid></control><display><type>article</type><title>miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Kousar, Kousain ; Ahmad, Tahir ; Abduh, Maisa S ; Kanwal, Balquees ; Shah, Syeda Saba ; Naseer, Faiza ; Anjum, Sadia</creator><creatorcontrib>Kousar, Kousain ; Ahmad, Tahir ; Abduh, Maisa S ; Kanwal, Balquees ; Shah, Syeda Saba ; Naseer, Faiza ; Anjum, Sadia</creatorcontrib><description>miRNAs are 20-22 long nucleotide non-coding ribonucleic acid molecules critical to the modulation of molecular pathways. Immune evasion and the establishment of a suitable tumor microenvironment are two major contributors that support tumor invasion and metastasis. Tumorigenic miRNAs support these two hallmarks by desensitizing important tumor-sensitive regulatory cells such as dendritic cells, M1 macrophages, and T helper cells towards tumors while supporting infiltration and proliferation of immune cells like Treg cells, tumor-associated M2 macrophages that promote self-tolerance and chronic inflammation. miRNAs have a significant role in enhancing the efficacies of immunotherapy treatments like checkpoint blockade therapy, adoptive T cell therapy, and oncolytic virotherapy in cancer. A clear understanding of the role of miRNA can help scientists to formulate better-targeted treatment modalities. miRNA therapeutics have emerged as diverse class of nucleic acid-based molecules that can suppress oncogenic miRNAs and promote the expression of tumor suppressor miRNAs.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms232213822</identifier><identifier>PMID: 36430305</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Angiogenesis ; Antigens ; Biosynthesis ; Breast cancer ; Cell proliferation ; Cell therapy ; Chemoresistance ; Chemotherapy ; Cytoplasm ; Cytotoxicity ; Dendritic cells ; Desensitization ; Enzymes ; Epigenetics ; Genomes ; Helper cells ; Humans ; Immune checkpoint ; Immune system ; Immunologic Factors ; Immunological tolerance ; Immunology ; Immunoregulation ; Immunotherapy ; Ligands ; Lymphocytes ; Lymphocytes T ; Macrophages ; Metabolism ; Metastases ; Metastasis ; MicroRNAs ; MicroRNAs - metabolism ; miRNA ; Neoplasms - genetics ; Neoplasms - therapy ; Nucleotides ; Oncolysis ; Proteins ; Review ; RNA polymerase ; Self ; Tumor microenvironment ; Tumor Microenvironment - genetics ; Tumor suppressor genes ; Tumors</subject><ispartof>International journal of molecular sciences, 2022-11, Vol.23 (22), p.13822</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-dfd56de0d4ff9f081012dc773426f75c4ee76be37da7540d317f8fe2a6d3a7933</citedby><cites>FETCH-LOGICAL-c415t-dfd56de0d4ff9f081012dc773426f75c4ee76be37da7540d317f8fe2a6d3a7933</cites><orcidid>0000-0002-7231-3386</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2739442867/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2739442867?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25728,27898,27899,36986,36987,44563,53763,53765,75093</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36430305$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kousar, Kousain</creatorcontrib><creatorcontrib>Ahmad, Tahir</creatorcontrib><creatorcontrib>Abduh, Maisa S</creatorcontrib><creatorcontrib>Kanwal, Balquees</creatorcontrib><creatorcontrib>Shah, Syeda Saba</creatorcontrib><creatorcontrib>Naseer, Faiza</creatorcontrib><creatorcontrib>Anjum, Sadia</creatorcontrib><title>miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>miRNAs are 20-22 long nucleotide non-coding ribonucleic acid molecules critical to the modulation of molecular pathways. Immune evasion and the establishment of a suitable tumor microenvironment are two major contributors that support tumor invasion and metastasis. Tumorigenic miRNAs support these two hallmarks by desensitizing important tumor-sensitive regulatory cells such as dendritic cells, M1 macrophages, and T helper cells towards tumors while supporting infiltration and proliferation of immune cells like Treg cells, tumor-associated M2 macrophages that promote self-tolerance and chronic inflammation. miRNAs have a significant role in enhancing the efficacies of immunotherapy treatments like checkpoint blockade therapy, adoptive T cell therapy, and oncolytic virotherapy in cancer. A clear understanding of the role of miRNA can help scientists to formulate better-targeted treatment modalities. miRNA therapeutics have emerged as diverse class of nucleic acid-based molecules that can suppress oncogenic miRNAs and promote the expression of tumor suppressor miRNAs.</description><subject>Angiogenesis</subject><subject>Antigens</subject><subject>Biosynthesis</subject><subject>Breast cancer</subject><subject>Cell proliferation</subject><subject>Cell therapy</subject><subject>Chemoresistance</subject><subject>Chemotherapy</subject><subject>Cytoplasm</subject><subject>Cytotoxicity</subject><subject>Dendritic cells</subject><subject>Desensitization</subject><subject>Enzymes</subject><subject>Epigenetics</subject><subject>Genomes</subject><subject>Helper cells</subject><subject>Humans</subject><subject>Immune checkpoint</subject><subject>Immune system</subject><subject>Immunologic Factors</subject><subject>Immunological tolerance</subject><subject>Immunology</subject><subject>Immunoregulation</subject><subject>Immunotherapy</subject><subject>Ligands</subject><subject>Lymphocytes</subject><subject>Lymphocytes T</subject><subject>Macrophages</subject><subject>Metabolism</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>MicroRNAs</subject><subject>MicroRNAs - metabolism</subject><subject>miRNA</subject><subject>Neoplasms - genetics</subject><subject>Neoplasms - therapy</subject><subject>Nucleotides</subject><subject>Oncolysis</subject><subject>Proteins</subject><subject>Review</subject><subject>RNA polymerase</subject><subject>Self</subject><subject>Tumor microenvironment</subject><subject>Tumor Microenvironment - genetics</subject><subject>Tumor suppressor genes</subject><subject>Tumors</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkUtLJDEUhcOgjI66dCsBNy6smbyqUrURpJmHoCNIuw6xcmOnqSRtUiW4nV8-sdVGXSVwvntuTg5Ch5R857wjP9zSZ8YZo7xl7AvapYKxipBGbr2776BvOS8JKWDdfUU7vBGccFLvon_e3fw9z9gFfAP306BHFwOOFs8nHxO-cn2KEB5disFDGE_xbAE-jgtIevVURrLLow49nOIL76ewUa6ieTPTweD1FjxfizCNrl9vnD1Ppn20bfWQ4eD13EO3v37OZ3-qy-vfF7Pzy6oXtB4rY03dGCBGWNtZ0lJCmeml5II1Vta9AJDNHXBptKwFMZxK21pgujFcy47zPXT24rua7jyYvsRJelCr5LxOTypqpz4qwS3UfXxUXdN1RIpicPJqkOLDBHlU3uUehkEHiFNWTApSk1ZIWtDjT-gyTimUeIXinRCsbWShqheqfHLOCezmMZSo53bVh3YLf_Q-wYZ-q5P_BypNo1k</recordid><startdate>20221110</startdate><enddate>20221110</enddate><creator>Kousar, Kousain</creator><creator>Ahmad, Tahir</creator><creator>Abduh, Maisa S</creator><creator>Kanwal, Balquees</creator><creator>Shah, Syeda Saba</creator><creator>Naseer, Faiza</creator><creator>Anjum, Sadia</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7231-3386</orcidid></search><sort><creationdate>20221110</creationdate><title>miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer</title><author>Kousar, Kousain ; Ahmad, Tahir ; Abduh, Maisa S ; Kanwal, Balquees ; Shah, Syeda Saba ; Naseer, Faiza ; Anjum, Sadia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-dfd56de0d4ff9f081012dc773426f75c4ee76be37da7540d317f8fe2a6d3a7933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Angiogenesis</topic><topic>Antigens</topic><topic>Biosynthesis</topic><topic>Breast cancer</topic><topic>Cell proliferation</topic><topic>Cell therapy</topic><topic>Chemoresistance</topic><topic>Chemotherapy</topic><topic>Cytoplasm</topic><topic>Cytotoxicity</topic><topic>Dendritic cells</topic><topic>Desensitization</topic><topic>Enzymes</topic><topic>Epigenetics</topic><topic>Genomes</topic><topic>Helper cells</topic><topic>Humans</topic><topic>Immune checkpoint</topic><topic>Immune system</topic><topic>Immunologic Factors</topic><topic>Immunological tolerance</topic><topic>Immunology</topic><topic>Immunoregulation</topic><topic>Immunotherapy</topic><topic>Ligands</topic><topic>Lymphocytes</topic><topic>Lymphocytes T</topic><topic>Macrophages</topic><topic>Metabolism</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>MicroRNAs</topic><topic>MicroRNAs - metabolism</topic><topic>miRNA</topic><topic>Neoplasms - genetics</topic><topic>Neoplasms - therapy</topic><topic>Nucleotides</topic><topic>Oncolysis</topic><topic>Proteins</topic><topic>Review</topic><topic>RNA polymerase</topic><topic>Self</topic><topic>Tumor microenvironment</topic><topic>Tumor Microenvironment - genetics</topic><topic>Tumor suppressor genes</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kousar, Kousain</creatorcontrib><creatorcontrib>Ahmad, Tahir</creatorcontrib><creatorcontrib>Abduh, Maisa S</creatorcontrib><creatorcontrib>Kanwal, Balquees</creatorcontrib><creatorcontrib>Shah, Syeda Saba</creatorcontrib><creatorcontrib>Naseer, Faiza</creatorcontrib><creatorcontrib>Anjum, Sadia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kousar, Kousain</au><au>Ahmad, Tahir</au><au>Abduh, Maisa S</au><au>Kanwal, Balquees</au><au>Shah, Syeda Saba</au><au>Naseer, Faiza</au><au>Anjum, Sadia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2022-11-10</date><risdate>2022</risdate><volume>23</volume><issue>22</issue><spage>13822</spage><pages>13822-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>miRNAs are 20-22 long nucleotide non-coding ribonucleic acid molecules critical to the modulation of molecular pathways. Immune evasion and the establishment of a suitable tumor microenvironment are two major contributors that support tumor invasion and metastasis. Tumorigenic miRNAs support these two hallmarks by desensitizing important tumor-sensitive regulatory cells such as dendritic cells, M1 macrophages, and T helper cells towards tumors while supporting infiltration and proliferation of immune cells like Treg cells, tumor-associated M2 macrophages that promote self-tolerance and chronic inflammation. miRNAs have a significant role in enhancing the efficacies of immunotherapy treatments like checkpoint blockade therapy, adoptive T cell therapy, and oncolytic virotherapy in cancer. A clear understanding of the role of miRNA can help scientists to formulate better-targeted treatment modalities. miRNA therapeutics have emerged as diverse class of nucleic acid-based molecules that can suppress oncogenic miRNAs and promote the expression of tumor suppressor miRNAs.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>36430305</pmid><doi>10.3390/ijms232213822</doi><orcidid>https://orcid.org/0000-0002-7231-3386</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2022-11, Vol.23 (22), p.13822
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9699074
source Publicly Available Content Database; PubMed Central
subjects Angiogenesis
Antigens
Biosynthesis
Breast cancer
Cell proliferation
Cell therapy
Chemoresistance
Chemotherapy
Cytoplasm
Cytotoxicity
Dendritic cells
Desensitization
Enzymes
Epigenetics
Genomes
Helper cells
Humans
Immune checkpoint
Immune system
Immunologic Factors
Immunological tolerance
Immunology
Immunoregulation
Immunotherapy
Ligands
Lymphocytes
Lymphocytes T
Macrophages
Metabolism
Metastases
Metastasis
MicroRNAs
MicroRNAs - metabolism
miRNA
Neoplasms - genetics
Neoplasms - therapy
Nucleotides
Oncolysis
Proteins
Review
RNA polymerase
Self
Tumor microenvironment
Tumor Microenvironment - genetics
Tumor suppressor genes
Tumors
title miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-26T18%3A52%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=miRNAs%20in%20Regulation%20of%20Tumor%20Microenvironment,%20Chemotherapy%20Resistance,%20Immunotherapy%20Modulation%20and%20miRNA%20Therapeutics%20in%20Cancer&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Kousar,%20Kousain&rft.date=2022-11-10&rft.volume=23&rft.issue=22&rft.spage=13822&rft.pages=13822-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms232213822&rft_dat=%3Cproquest_pubme%3E2739442867%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c415t-dfd56de0d4ff9f081012dc773426f75c4ee76be37da7540d317f8fe2a6d3a7933%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2739442867&rft_id=info:pmid/36430305&rfr_iscdi=true